{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T21:57:12Z","timestamp":1763071032140,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["NHCR-HC17C0020"],"award-info":[{"award-number":["NHCR-HC17C0020"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11096-018-0739-0","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:26:46Z","timestamp":1540513606000},"page":"1568-1576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Signal detection of benzodiazepine use and risk of dementia: sequence symmetry analysis using South Korean national healthcare database"],"prefix":"10.1007","volume":"40","author":[{"given":"Kyung-Rock","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu-Beom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon-Hee","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hi Gin","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Tae","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eui-Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2791-1037","authenticated-orcid":false,"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,26]]},"reference":[{"issue":"7","key":"739_CR1","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3346\/jkms.2014.29.7.903","volume":"29","author":"YJ Kim","year":"2014","unstructured":"Kim YJ, Han JW, So YS, et al. Prevalence and trends of dementia in Korea: a systematic review and meta analysis. J Korean Med Sci. 2014;29(7):903\u201312.","journal-title":"J Korean Med Sci"},{"issue":"10","key":"739_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11920-016-0727-9","volume":"18","author":"G Airagnes","year":"2016","unstructured":"Airagnes G, Pelissolo A, Lavall\u00e9e M, et al. BZD misuse in the elderly: risk factors, consequences, and management. Curr Psychiatry Rep. 2016;18(10):89.","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"739_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40263-015-0305-4","volume":"30","author":"A Pariente","year":"2016","unstructured":"Pariente A, de Gage SB, Moore N, et al. The BZD\u2013dementia disorders link: current state of knowledge. CNS Drugs. 2016;30(1):1\u20137.","journal-title":"CNS Drugs"},{"issue":"5","key":"739_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","volume":"12","author":"D Shash","year":"2016","unstructured":"Shash D, Kurth T, Bertrand M, et al. BZD, psychotropic medication, and dementia: a population-based cohort study. Alzheimers Dement. 2016;12(5):604\u201313.","journal-title":"Alzheimers Dement"},{"key":"739_CR5","doi-asserted-by":"publisher","first-page":"e6231","DOI":"10.1136\/bmj.e6231","volume":"345","author":"BG Sophie","year":"2012","unstructured":"Sophie BG, Bernard B, Fabienne B, et al. BZD use and risk of dementia: prospective population based study. BMJ. 2012;345:e6231.","journal-title":"BMJ"},{"key":"739_CR6","first-page":"i90","volume":"352","author":"G Shelly","year":"2016","unstructured":"Shelly G, Dublin S, Yu O et al. BZD use and risk of incident dementia or cognitive decline: prospective population based study. BMJ. 2016;352:i90","journal-title":"BMJ"},{"issue":"6","key":"739_CR7","first-page":"2433","volume":"8","author":"B Proy-vega","year":"2017","unstructured":"Proy-vega B, Martines BA, Solis Garcia DPJ, et al. Pharmacovigilance signals detection: BZDs and skin and subcutaneous tissue disorders. IJPSR. 2017;8(6):2433\u201342.","journal-title":"IJPSR"},{"key":"739_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/pds.3417","volume":"22","author":"IA Wahab","year":"2013","unstructured":"Wahab IA, Nicole LP, et al. The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection. Pharmacoepidemiol Drug Saf. 2013;22:496\u2013502.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"739_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s40264-013-0124-9","volume":"37","author":"IA Wahab","year":"2014","unstructured":"Wahab IA, Nicole LP, et al. Comparing time to adverse drug reaction signals in a spontaneous reporting database and a claims database: a case study of rofecoxib-induced myocardial infarction and rosiglitazone-induced heart failure signals in Australia. Drug Saf. 2014;37(1):53\u201364.","journal-title":"Drug Saf"},{"key":"739_CR10","first-page":"4","volume":"2","author":"IA Wahab","year":"2013","unstructured":"Wahab IA, Nicole LP, et al. Sequence symmetry analysis and disproportionality analyses: what percentage of adverse drug reaction do they signal? Drug Saf. 2013;2:4.","journal-title":"Drug Saf"},{"key":"739_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10654-017-0281-8","volume":"32","author":"E Lai","year":"2017","unstructured":"Lai E, Pratt N, Hsieh C, et al. Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies. Eur J Epidemiol. 2017;32:567\u201382.","journal-title":"Eur J Epidemiol"},{"key":"739_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/00001648-199609000-00005","volume":"7","author":"J Hallas","year":"1996","unstructured":"Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology. 1996;7:478\u201384.","journal-title":"Epidemiology"},{"issue":"11","key":"739_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7150\/ijms.16185","volume":"13","author":"T Mitsutaka","year":"2016","unstructured":"Mitsutaka T, Mai F, Kouichi H. Association between BZD Use and dementia: data mining of different medical databases. Int J Med Sci. 2016;13(11):825\u201334.","journal-title":"Int J Med Sci"},{"issue":"Suppl 1","key":"739_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/pds.2330","volume":"21","author":"M Maclure","year":"2012","unstructured":"Maclure M, Fireman B, Nelson JC, et al. When should case-only designs be used for safety monitoring of medical products? Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):50\u201361.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"739_CR15","doi-asserted-by":"publisher","first-page":"472","DOI":"10.5414\/CP202974","volume":"55","author":"SY Park","year":"2017","unstructured":"Park SY, Bae S, Shin JY. Real-world patterns of long-acting BZD prescription among elderly Koreans in 2013. Int J Clin Pharmacol Ther. 2017;55(6):472\u20139.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"739_CR16","doi-asserted-by":"publisher","first-page":"g5205","DOI":"10.1136\/bmj.g5205","volume":"349","author":"BS Gage de","year":"2014","unstructured":"de Gage BS, Moride Y, Ducruet T, et al. BZD use and risk of Alzheimer\u2019s disease: case\u2013control study. BMJ. 2014;349:g5205.","journal-title":"BMJ"},{"issue":"11","key":"739_CR17","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","volume":"11","author":"Y Stern","year":"2012","unstructured":"Stern Y. Cognitive reserve in ageing and Alzheimer\u2019s disease. Lancet Neurol. 2012;11(11):1006\u201312.","journal-title":"Lancet Neurol"},{"issue":"7","key":"739_CR18","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/13803395.2014.928268","volume":"36","author":"EK Stranks","year":"2014","unstructured":"Stranks EK, Crowe SF. The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis. J Clin Exp Neuropsychol. 2014;36(7):691\u2013700.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"8","key":"739_CR19","first-page":"639","volume":"29","author":"C Tannenbaum","year":"2012","unstructured":"Tannenbaum C, Paquette A, Hilmer S, et al. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging. 2012;29(8):639\u201358.","journal-title":"Drugs Aging"},{"issue":"1","key":"739_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0301-0082(96)00011-1","volume":"49","author":"MA Hutchinson","year":"1996","unstructured":"Hutchinson MA, Smith PF, Darlington CL. The behavioural and neuronal effects of the chronic administration of BZD anxiolytic and hypnotic drugs. Prog Neurobiol. 1996;49(1):73\u201397.","journal-title":"Prog Neurobiol"},{"issue":"4","key":"739_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/ana.410230419","volume":"23","author":"S Shimohama","year":"1988","unstructured":"Shimohama S, Taniguchi T, Fujiwara M, et al. Changes in BZD receptors in Alzheimer-type dementia. Ann Neurol. 1988;23(4):404\u20136.","journal-title":"Ann Neurol"},{"issue":"25","key":"739_CR22","doi-asserted-by":"publisher","first-page":"10071","DOI":"10.1073\/pnas.1204606109","volume":"109","author":"A Limon","year":"2012","unstructured":"Limon A, Reyes-Ruiz JM, Miledi R. Loss of functional GABAA receptors in the Alzheimer diseased brain. Proc Natl Acad Sci USA. 2012;109(25):10071\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"739_CR23","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nm.3639","volume":"20","author":"S Jo","year":"2014","unstructured":"Jo S, Yarishkin O, Hwang YJ, et al. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer\u2019s disease. Nat Med. 2014;20(8):886\u201396.","journal-title":"Nat Med"},{"issue":"8","key":"739_CR24","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/pds.3780","volume":"24","author":"Nicole Pratt","year":"2015","unstructured":"Pratt Nicole, Chan Esther W, et al. Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries. Pharmacoepidemiol Drug Saf. 2015;24(8):858\u201364.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-018-0739-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-018-0739-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-018-0739-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T21:00:33Z","timestamp":1572037233000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-018-0739-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,26]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1007\/s11096-018-0739-0","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"type":"print","value":"2210-7703"},{"type":"electronic","value":"2210-7711"}],"subject":[],"published":{"date-parts":[[2018,10,26]]},"assertion":[{"value":"17 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was supported by a Grant from the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant no.: NHCR-HC17C0020).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}